Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View item
  • Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

Thumbnail
View/Open
Published version (613.2Kb)
Date
2016-08
ICR Author
Oyen, Willem
Author
Van Cutsem, E
Cervantes, A
Adam, R
Sobrero, A
Van Krieken, JH
Aderka, D
Aranda Aguilar, E
Bardelli, A
Benson, A
Bodoky, G
Ciardiello, F
D'Hoore, A
Diaz-Rubio, E
Douillard, J-Y
Ducreux, M
Falcone, A
Grothey, A
Gruenberger, T
Haustermans, K
Heinemann, V
Hoff, P
Köhne, C-H
Labianca, R
Laurent-Puig, P
Ma, B
Maughan, T
Muro, K
Normanno, N
Österlund, P
Oyen, WJG
Papamichael, D
Pentheroudakis, G
Pfeiffer, P
Price, TJ
Punt, C
Ricke, J
Roth, A
Salazar, R
Scheithauer, W
Schmoll, HJ
Tabernero, J
Taïeb, J
Tejpar, S
Wasan, H
Yoshino, T
Zaanan, A
Arnold, D
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients with metastatic CRC (mCRC) has improved greatly due not only to an increase in the number of patients being referred for and undergoing surgical resection of their localised metastatic disease but also to a more strategic approach to the delivery of systemic therapy and an expansion in the use of ablative techniques. This reflects the increase in the number of patients that are being managed within a multidisciplinary team environment and specialist cancer centres, and the emergence over the same time period not only of improved imaging techniques but also prognostic and predictive molecular markers. Treatment decisions for patients with mCRC must be evidence-based. Thus, these ESMO consensus guidelines have been developed based on the current available evidence to provide a series of evidence-based recommendations to assist in the treatment and management of patients with mCRC in this rapidly evolving treatment setting.
URI
https://repository.icr.ac.uk/handle/internal/281
DOI
https://doi.org/10.1093/annonc/mdw235
Collections
  • Radiotherapy and Imaging
Subject
Humans
Colorectal Neoplasms
Neoplasm Metastasis
Prognosis
Guidelines as Topic
Molecular Targeted Therapy
Biomarkers, Tumor
Research team
Translational Molecular Imaging
Language
eng
Date accepted
2016-05-31
License start date
2016-08
Citation
Annals of oncology : official journal of the European Society for Medical Oncology, 2016, 27 (8), pp. 1386 - 1422

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.